54
Participants
Start Date
May 16, 2017
Primary Completion Date
August 20, 2017
Study Completion Date
August 20, 2017
HTL0018318
Part A single dose Part B five doses
Placebo oral capsule
Part B only
Richmond Pharmacology, London
Nxera Pharma UK Limited
INDUSTRY